爱伦医疗
(920050)
| 流通市值：5.26亿 | | | 总市值：19.67亿 |
| 流通股本：1810.27万 | | | 总股本：6767.93万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 641,650,456.84 | 294,537,632.66 | 988,730,443.01 | 689,622,115.17 |
| 营业总成本 | 568,435,337.08 | 270,217,152.17 | 884,757,579.38 | 614,713,079.43 |
| 其他经营收益 | | | | |
| 营业利润 | 61,229,390 | 23,525,156.57 | 102,806,046.21 | 77,628,685.55 |
| 利润总额 | 59,535,353.09 | 23,559,392.81 | 101,982,397.89 | 77,119,585.11 |
| 净利润 | 57,296,353.56 | 21,379,798.94 | 93,491,526.55 | 73,086,602.69 |
| 每股收益 | | | | |
| 其他综合收益 | -22,224,125.59 | -14,249,850.65 | 10,119,796.38 | 8,683,702.91 |
| 综合收益总额 | 35,072,227.97 | 7,129,948.29 | 103,611,322.93 | 81,770,305.6 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 599,952,456.79 | 661,915,454.59 | 412,913,680.13 | 412,503,494.95 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,010,468,234.17 | 979,796,502.49 | 950,277,595.52 | 866,290,112.79 |
| 资产总计 | 1,610,420,690.96 | 1,641,711,957.08 | 1,363,191,275.65 | 1,278,793,607.74 |
| 流动负债: | | | | |
| 流动负债合计 | 521,745,469.36 | 492,818,724.13 | 484,854,618.42 | 414,300,987.86 |
| 非流动负债: | | | | |
| 非流动负债合计 | 15,545,343.55 | 35,715,843.7 | 33,764,219 | 43,160,413.17 |
| 负债合计 | 537,290,812.91 | 528,534,567.83 | 518,618,837.42 | 457,461,401.03 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,048,231,351.87 | 1,085,779,586.73 | 835,280,218.21 | 811,837,223.49 |
| 股东权益合计 | 1,073,129,878.05 | 1,113,177,389.25 | 844,572,438.23 | 821,332,206.71 |
| 负债和股东权益合计 | 1,610,420,690.96 | 1,641,711,957.08 | 1,363,191,275.65 | 1,278,793,607.74 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 697,264,110.8 | 367,053,562.09 | 1,088,035,095.15 | 779,721,574.91 |
| 经营活动现金流出小计 | 624,066,682.93 | 294,546,054.33 | 1,015,404,160 | 744,180,731.38 |
| 经营活动产生的现金流量净额 | 73,197,427.87 | 72,507,507.76 | 72,630,935.15 | 35,540,843.53 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,526,408.17 | 3,539,338.02 | 43,784,651.33 | 40,223,560.81 |
| 投资活动现金流出小计 | 171,068,784.23 | 74,596,330.45 | 300,432,995.21 | 239,869,298.49 |
| 投资活动产生的现金流量净额 | -167,542,376.06 | -71,056,992.43 | -256,648,343.88 | -199,645,737.68 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 421,231,477.99 | 351,531,477.99 | 417,800,000 | 328,300,000 |
| 筹资活动现金流出小计 | 224,191,495.6 | 42,196,173.66 | 253,979,501.69 | 184,744,994.69 |
| 筹资活动产生的现金流量净额 | 197,039,982.39 | 309,335,304.33 | 163,820,498.31 | 143,555,005.31 |
| 汇率变动对现金及现金等价物的影响 | -12,277,789.85 | -5,287,383.02 | 4,034,927.49 | 3,700,893.11 |
| 现金及现金等价物净增加额 | 90,417,244.35 | 305,498,436.64 | -16,161,982.93 | -16,848,995.73 |
| 期末现金及现金等价物余额 | 147,198,358.18 | 362,279,550.47 | 56,781,113.83 | 56,094,101.03 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 90,417,244.35 | - | -16,161,982.93 | -16,848,995.73 |